Among the 46,588 tumor samples in the “curated set of nonredundant studies”, ATM and ATR are mutated in many different cancer types with the frequency ranging from ~1% for brain or testicular cancer to ~8–10% for endometrial, bladder, or colorectal cancer (Fig. 1e and Supplementary Table 1). This evidence concerns the gene ATM and neoplasm.